Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
暂无分享,去创建一个
Antonio Colombo | Patrick W Serruys | A Pieter Kappetein | M. Mack | P. Serruys | F. Mohr | T. Feldman | D. Holmes | M. Morice | A. Colombo | A. Kappetein | M. Morel | K. Dawkins | Nic Van Dyck | David R Holmes | E. Ståhle | Elisabeth Ståhle | Friedrich W Mohr | Keith D Dawkins | Michael J Mack | Marie-Claude Morice | Marie-angèle Morel | Vicki M Houle | Ted E Feldman | Nic Van Dyck | Vicki M. Houle | N. V. Dyck | A. Kappetein | David R. Holmes | Ted E. Feldman | P. Serruys | Friedrich W. Mohr | Friedrich W Mohr | A Pieter Kappetein | Ted E Feldman | Michael J Mack | Nic Van Dyck | Vicki M Houle | Keith D Dawkins | Patrick W Serruys | Michael J. Mack | Vicki M Houle | M. J. Mack | Vicki M Houle
[1] Antonio Colombo,et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. , 2010, Journal of the American College of Cardiology.
[2] P. Bannon,et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. , 2011, The Journal of thoracic and cardiovascular surgery.
[3] L. Mauri. Why we still need randomized trials to compare effectiveness. , 2012, The New England journal of medicine.
[4] Timothy J Gardner,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[5] B. Horne,et al. Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry , 2007, Circulation.
[6] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[7] E. Steyerberg,et al. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years. , 2012, JACC: Cardiovascular Interventions.
[8] E. Hannan,et al. Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.
[9] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.
[10] Gregg W Stone,et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. , 2010, The New England journal of medicine.
[11] R. Califf,et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. , 2006, The Annals of thoracic surgery.
[12] Akshay S. Desai,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.
[13] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.
[14] Nikola Jagic,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.
[15] B. Gersh,et al. Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2010, Circulation.
[16] Antonio Colombo,et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. , 2011, European heart journal.
[17] I. Palacios,et al. Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[18] Soonchang Hong,et al. Comparison of long-term outcome of off-pump coronary artery bypass grafting versus drug-eluting stents in triple-vessel coronary artery disease. , 2012, American Journal of Cardiology.
[19] B. Medalion,et al. Drug-eluting stents compared with bilateral internal thoracic artery grafts for diabetic patients. , 2012, The Annals of thoracic surgery.
[20] P. Teirstein,et al. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting. , 2010, The American journal of cardiology.
[21] I. Palacios,et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). , 2005, Journal of the American College of Cardiology.
[22] G. Schuler,et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. , 2011, Journal of the American College of Cardiology.
[23] M. Jeong,et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgi , 2010, Journal of the American College of Cardiology.
[24] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.
[25] R. Hall,et al. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease , 2010, Journal of cardiovascular medicine.
[26] Sean M. O'Brien,et al. Comparative effectiveness of revascularization strategies. , 2012, The New England journal of medicine.
[27] P. Serruys,et al. Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease , 2004, Circulation.
[28] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[29] Seung‐Jung Park,et al. Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry. , 2011, Journal of the American College of Cardiology.
[30] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[31] O. Alfieri,et al. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. , 2010, JACC. Cardiovascular interventions.
[32] J. Pepper,et al. Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS) , 2008, Circulation.
[33] R. Favaloro,et al. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. , 1968, The Annals of thoracic surgery.
[34] D. Dudek,et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. , 2008, Journal of the American College of Cardiology.
[35] P. Serruys,et al. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[36] Patrick W Serruys,et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. , 2006, American heart journal.
[37] B. Gersh,et al. Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease , 2007 .
[38] John R. Robinson,et al. Influence of anastomotic techniques in totally endoscopic coronary artery bypass , 2006, The international journal of medical robotics + computer assisted surgery : MRCAS.
[39] P. Serruys,et al. The SYNTAX score and SYNTAX-based clinical risk scores. , 2011, Seminars in thoracic and cardiovascular surgery.
[40] M. Jeong,et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. , 2011, The New England journal of medicine.